Aminoglutethimide is an investigational agent of proven benefit in the treatment of metastatic breast carcinoma. We report herein a case of aminoglutethimide-induced pancytopenia complicated by bleeding and gram-negative septicemia. Severe pancytopenia is a rare but important side effect of this new drug and is rapidly reversible when the agent is withdrawn.
|Original language||English (US)|
|Number of pages||3|
|Journal||Cancer Treatment Reports|
|Publication status||Published - Dec 1 1978|
All Science Journal Classification (ASJC) codes
- Cancer Research